Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for 6'-Sialyllactose.
6'-Sialyllactose is a major human milk oligosaccharide (HMO) that functions as a prebiotic and decoy receptor to modulate gut microbiota composition and inhibit the adhesion of enteric pathogens to the intestinal epithelium.
439196
154.3 g/mol
-0.4
(2R,3R)-1,4-bis(sulfanyl)butane-2,3-diol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for 6'-Sialyllactose across standard consumer modalities.
The hygroscopic nature of 6'-SL requires low-moisture excipients and potentially specialized HPMC capsules to prevent clumping or degradation over time.
High concentrations of 6'-SL may interfere with pectin gelation kinetics or result in a sticky texture due to its sugar-like physical properties and moisture-binding capacity.
The high effective dosage required for HMOs significantly exceeds the typical 20-50mg payload capacity of thin-film oral strip matrices.
Ready to launch a product featuring 6'-Sialyllactose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your 6'-Sialyllactose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your 6'-Sialyllactose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation